Ventoux Biosciences

Dupuytren's Disease

Dupuytren's Disease

A Chronic, Debilitating, Irreversible Disease

Dupuytren’s Contracture is a genetic, connective tissue disease of the hand that effects upwards of 1 in 20 adults.  Dupuytren’s is frequently under-treated due to few and predominantly surgical, treatment options

Dupuytren's Contracture

Physicians & Patients need more options

Patients with Dupuytren’s disease suffer from decreased  / lost hand function, loss of hand mobility, pain, negative economic impact due to lost work, withdrawal from activities of daily living, and reduced quality of life (QoL). 

No cure exists

Novel treatments to improve patient outcomes as well as modify the course of disease are clinically warranted. 

Significant unmet Medical need & Large addressable population

>30 million

Estimated Prevalence in United States and Europe

Up to 85%

Post Operative Disease Recurrence


FDA Approved Product (Severe Dupuytrens Only)